Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Tel: +44 (0)1273 434 943
Email: [email protected]
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that healthcare professionals in England should consider using FLUAD for the 2018-19 flu season. This is because it is both more effective in preventing influenza, and more cost-effective in the 65 years and over age group, when compared to conventional non-adjuvanted vaccines. FLUAD is an enhanced vaccine that has been shown in multiple studies to provide better protection against influenza for older people than conventional non-adjuvanted vaccines. This advantage was recognised by the JCVI at its meeting in June 2017. This decision comes after Public Health England declared that conventional
---------------------------
This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.